Study Shows Stereotactic Biopsy System Delivers Greater Accuracy in Detecting Cancer and Planning for Targeted Prostate Cancer Therapies

ATLANTA, GA and MOBILE, AL--(HSMN NewsFeed)--Mar 27, 2009 -- Urologists convening this week at the Southeast Conference of the American Urological Association (AUA) in Mobile will deliver results from a study of a prostate biopsy targeting method that guides accurate and reproducible prostate biopsies. Additionally, the preliminary data shows that the stereotactic biopsy system, called TargetScan, may be used to guide delivery of targeted, focal prostate cancer therapies.

Full text >>